Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Botox
Pharma
Ipsen’s Botox rival Dysport posts dual ph. 3 wins in migraine
Dysport is now the first botulinum toxin to report positive phase 3 results in both episodic and chronic migraines, according to Ipsen.
Angus Liu
Jul 9, 2026 10:36am
AbbVie, Grace Therapeutics receive manufacturing-related CRLs
Apr 24, 2026 11:37am
AbbVie sues HHS, CMS over Botox's inclusion in IRA price talks
Feb 12, 2026 1:45am
AbbVie awarded $56M in Botox patent infringement case
Jul 22, 2025 11:22am
Revance is being bought up by Crown Laboratories for $924M
Aug 12, 2024 2:45pm
AbbVie's Skyrizi continues booming growth trajectory
Apr 26, 2024 12:06pm
